HopeStage
Back to all studies
CompletedNCT02651584

CAM2038 Buprenorphine Injections for Opioid Dependence

About this titleRead the official source — NCT02651584
Medication studyAges 18–65United StatesAddiction
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 65 years.

Listed locations
Birmingham and 35 more locationsSee all locations and recruitment
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateDecember 2015
Recruitment status
Completed
Enrollment listed in the registry
428
Sponsor
Braeburn Pharmaceuticals
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States
Age range
From 18 Years to 65 Years
Official registry ID
NCT02651584
Official title
Show the full official title

A Phase III, Randomized, Double-Blind, Active-Controlled, Parallel Group, Multi-center Trial Assessing the Efficacy and Safety of a Once-Weekly and Once-Monthly, Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Treatment of Adult Outpatients With Opioid Use Disorder

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Birmingham · Haleyville · Hamilton

32 more locations
  • Lemon Grove
  • Oceanside
  • Panorama City
  • San Diego
  • San Francisco
  • West Hollywood
  • Jacksonville
  • Lauderhill
  • Maitland
  • Miami
  • North Miami
  • Wichita
  • Lexington
  • Fall River
  • New Bedford
  • Flowood
  • St Louis
  • Belvidere
  • Berlin
  • New York
  • Canton
  • Dayton
  • Middleburg Heights
  • Oklahoma City
  • Conshohocken
  • Philadelphia
  • Lincoln
  • Charleston
  • Dallas
  • Orem
  • Burlington
  • Seattle

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Braeburn Pharmaceuticals.

Did this study involve medication?

Yes. The study involved medication, including CAM2038 SC injection, SL BPN/NX tabs, placebo SC injections and SL placebo tablets.

Who was this study for?

Listed age limits: 18 years to 65 years.

Want to explore more studies?

Explore studies